floatz AI
verifiedfloatz.ai
AI for drug discovery surfacing high-potential targets; coherent though thin metadata.
What it does
floatz AI for Drug Discovery helps surface high-potential drug targets grounded in human genetics, expression patterns, and biological pathways, built for translational success. It integrates human genetics, tissue expression, and pathway analysis to map billions of concepts and identify targets with real translational potential, delivering 3 clinically-relevant targets in 14 days.
Core features
AI-driven drug target identification
Integration of human genetics, tissue expression, and pathway analysis
Delivery of 3 clinically-relevant targets in 14 days
Multi-layered analysis (literature, omics, disease biology, competitive intelligence)
Expert-reviewed target selection
Best for
→Identifying novel drug targets for specific disease areas
→Expanding existing drug programs or exploring new therapeutic spaces
→Informing strategic decision-making or licensing evaluation for drug development